Download presentation
Presentation is loading. Please wait.
Published byPaolina Eva Bello Modified over 5 years ago
1
Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal Alphonse DeLucia, MD, Thomas W. Wakefield, MD, Philip C. Andrews, PhD, Brad J. Nichol, BS, Amy M. Kadell, Shirley K. Wrobleski, BS, L.Joe Downing, MD, James C. Stanley, MD Journal of Vascular Surgery Volume 18, Issue 1, Pages (July 1993) DOI: /mva Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
2
Fig. 1 Experimental protocol.
Journal of Vascular Surgery , 49-60DOI: ( /mva ) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
3
Fig. 2 Percent reversal of heparin anticoagulation achieved by variant peptides and n-protamine (protamine [+21P]) as assessed by ACT and heparin anti-factor Xa activity. Journal of Vascular Surgery , 49-60DOI: ( /mva ) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
4
Fig. 3 Percent reversal of heparin anticoagulation achieved by variant peptides and n-protamine (Protamine [+21P]) as assessed by TCT and heparin anti-factor IIa activity. Journal of Vascular Surgery , 49-60DOI: ( /mva ) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
5
Fig. 4 Mean arterial blood pressure and cardiac output changes observed with variant peptides and n-protamine (Prot.[+21]). Journal of Vascular Surgery , 49-60DOI: ( /mva ) Copyright © 1993 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.